SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
BSEM

BioStem Technologies, Inc. (BSEM)

NASDAQ: BSEM · USD
Healthcare · Biotechnology
$0.64-$0.07 (-10.23%)
 
Market cap
$12.2M
Insider Score
Market Cap$12.18M-83.5%
Revenue (ttm)$31.75M
Net Income-$40.43M
EPS$0.88
Shares Out19.18M
PE Ratio0.72
Forward PE2.19
Dividendn/a
Ex-Dividend Daten/a
Volume254,190
Open$0.70
Previous Close$0.71
Day's Range$0.53 - $0.71
52-Week Range$0.53 - $8.40
Beta0.69
Analystsnone
Price Target$7.00(+1002.19%)
Earnings DateNov 12, 2026
-9.54% (1D)
No price history available.

About BSEM

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.

Address
4901 Northwest 17th Way, Fort Lauderdale, FL, 33309, United States
Market Cap
12 million
Employees
73
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$14.30K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-10.31%
5 Days
-39.52%
1 Month
-61.75%
6 Months
-84.64%
1 Year
-83.51%

$BSEM stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in BSEM holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by BSEM's directors and management

Net Shares Purchased by Insiders−20k−10k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

BSEM Estimated quarterly lobbying spending

Source: U.S. Senate LDA

BSEM Revenue by Segment

$12.18MTotal
Compensation and related$6.93M56.95%
Professional fees$5.24M43.05%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New BSEM patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to BSEM from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from BSEM’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
60
News & Sentiment
20% of score
58

News check: Mixed Q3 results with revenue beat offset by sequential decline; hospital revenue growth shows operational strength.

Recent Insider Activity

Buys
0
Sells
1
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.